Author:
Milano G,Etienne M C,Pierrefite V,Barberi-Heyob M,Deporte-Fety R,Renée N
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Diasio, R. B. & Harris, B. E. (1989). Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 16: 215–237.
2. Diasio, R. B., Beavers, T. L. & Carpenter, J. T. (1988). Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil induced toxicity. J Clin Invest 81: 47–51.
3. Etienne, M. C., Lagrange, J. L., Dassonville, O., Fleming, R., Thyss, A., Renée, N., Schneider, M., Demard, F. & Milano, G. (1994). Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol 12: 2248–2253.
4. Fleming, R., Milano, G., Thyss, A., Etienne, M. C., Renée, N., Schneider, M. & Demard, F. (1992). Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res 52: 2899–2902.
5. Fleming, R. A., Milano, G., Gaspard, M. H., Bargnoux, P. J., Thyss, A., Plagne, R., Renée, N., Schneider, M. & Demard, F. (1993). Dihydropyrimidine dehydrogenase activity in cancer patients. Eur J Cancer 29: 740–744.
Cited by
239 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献